Article Menu
Need Help?
No Article Versions Notes Found
Cite
Lipton, N.J.; Jesin, J.; Warner, E.; Cao, X.; Kiss, A.; Desautels, D.; Jerzak, K.J. Willingness of Women with Early Estrogen Receptor–Positive Breast Cancer to Take Adjuvant CDK4/6 Inhibitors. Curr. Oncol. 2020, 27, 127-134. https://doi.org/10.3747/co.27.6131
Lipton NJ, Jesin J, Warner E, Cao X, Kiss A, Desautels D, Jerzak KJ. Willingness of Women with Early Estrogen Receptor–Positive Breast Cancer to Take Adjuvant CDK4/6 Inhibitors. Current Oncology. 2020; 27(3):127-134. https://doi.org/10.3747/co.27.6131
Chicago/Turabian StyleLipton, N.J., J. Jesin, E. Warner, X. Cao, A. Kiss, D. Desautels, and K.J. Jerzak. 2020. "Willingness of Women with Early Estrogen Receptor–Positive Breast Cancer to Take Adjuvant CDK4/6 Inhibitors" Current Oncology 27, no. 3: 127-134. https://doi.org/10.3747/co.27.6131
APA StyleLipton, N. J., Jesin, J., Warner, E., Cao, X., Kiss, A., Desautels, D., & Jerzak, K. J. (2020). Willingness of Women with Early Estrogen Receptor–Positive Breast Cancer to Take Adjuvant CDK4/6 Inhibitors. Current Oncology, 27(3), 127-134. https://doi.org/10.3747/co.27.6131
